Calistoga Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Calistoga Pharmaceuticals Ownership

Who owns Calistoga Pharmaceuticals?

Calistoga Pharmaceuticals is owned by Gilead Sciences. It was acquired on February 22, 2011.

Calistoga Pharmaceuticals Business Overview

Where is Calistoga Pharmaceuticals headquartered?

Calistoga Pharmaceuticals is headquartered in Seattle, Washington.

What sector is Calistoga Pharmaceuticals in?

Calistoga Pharmaceuticals is a life science company.

When was Calistoga Pharmaceuticals founded?

Calistoga Pharmaceuticals was founded in 2006.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Calistoga Pharmaceuticals, Inc.

2101 - 4th Avenue, Suite 1960,
Seattle, Washington 98121
United States,
206-728-4700
www.calistogapharma.com

Calistoga Pharmaceuticals is a drug discovery company focused on the development of products for the treatment of cancer and inflammatory diseases. The Company?s initial focus is to leverage a strong proprietary position around the composition and use of drugs against a unique PI3 kinase isoform, p110delta. Calistoga is a privately held organization headquartered in Seattle.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.